Statins vs. smoke: can a pill protect your heart and brain?
NCT ID NCT07462715
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether taking statins (a common cholesterol drug) can protect the heart and brain from the harmful effects of breathing bushfire smoke. Healthy adults aged 18-64 will be exposed to simulated smoke in a controlled setting, with some taking statins short-term (2 days) or long-term (12+ months). Researchers will measure changes in heart rate, blood pressure, inflammation, and thinking skills to see if statins offer any protection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 4
Runs after approval, following long-term safety and how well the treatment works in everyday use.
- Participants
-
About 100 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
May 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 68 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Good general health and, if aged 45 year or more, low to intermediate (\<10%) atherosclerotic cardiovascular disease (ASCVD) risk category, based on clinical data measured within 12 months prior to enrolment. Exclusion Criteria: * History of severe chronic lung diseases such as chronic obstructive pulmonary disease or asthma as determined by participants' care providers. * History of chest pain, irregular heartbeats, heart failure, heart attack, heart pacemaker or coronary bypass surgery. * High cardiovascular risk (\>10%) category on the ASCVD risk calculator or judged to be at high risk by study cardiologist, for those aged 45 years or older. * History of stroke, dementia or other neurological condition * Untreated high blood pressure (≥ 140 systolic, ≥ 90 diastolic) * History of autoimmune or inflammatory rheumatic disease (e.g., rheumatoid arthritis, systemic lupus erythematosus, spondyloarthritis). Osteoarthritis alone is not an exclusion. * History of immunodeficiency * Diabetes (any type) * Current medications: Long term medications that interact with atorvastatin (such as verapamil, digoxin and warfarin); Medications that affect heart rate variability including beta-blockers (such as atenolol, metoprolol, propranolol, and acebutolol), tricyclic antidepressants and selective serotonin reuptake inhibitors (such as amitriptyline, sertraline, fluoxetine or citalopram), or medications with anti-cholinergic action (such as promethazine or prochlorperazine); stimulant medications, such as those prescribed for ADHD (such as methylphenidate, dexamphetamine, lisdexamfetamine); anti-inflammatory, immunosuppressive or immune modulating medications including systemic corticosteroids (such as prednisolone, dexamethasone) and non-steroidal anti-inflammatory drugs (NSAIDS) (such as ibuprofen, naproxen or diclofenac) * Currently smoking, or have smoked: more than one pack of cigarettes in the past year, or have smoked more than 100 packs of cigarettes in their lifetime * Currently vaping or have vaped: more than 200 puffs in the last year, more than 20,000 puffs in their lifetime * Currently pregnant, attempting to become pregnant or breastfeeding * History of skin allergy to tape or electrodes * Inability to travel to the study site
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Healthy adults are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Menzies Institute for Medical Research
Hobart, Tasmania, 7000, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Carbs or protein before exercise: does sex change how your body burns fuel?
- Two brain scanners, one stimulation session: can they agree?
- First human test of experimental pill XH-S004 begins in healthy volunteers
- Can video games keep your brain sharp? trial pits xbox against Paper-and-Pencil training
- Ultrasound pulses aimed at deep brain regions tied to empathy and impulse control
- A dead Probiotic's ghost may help tame weight gain